Familial cancer refers to cancers that occur more frequently within families due to shared genetic mutations. Understanding the genetic basis of familial cancer is crucial for cancer research, as it helps identify individuals at higher risk and allows for tailored prevention and treatment strategies. Researchers study familial cancer syndromes to uncover specific genetic alterations that predispose individuals to certain types of cancer, such as BRCA1 and BRCA2 mutations in breast and ovarian cancer. By elucidating these genetic factors, scientists can develop targeted therapies and screening protocols to detect cancer at earlier stages, potentially saving lives. Moreover, studying familial cancer sheds light on broader mechanisms of carcinogenesis, offering insights into the molecular pathways underlying various cancer types and driving advancements in precision medicine.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States